Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.
The FDA approval given to Musk's start-up Neuralink allows for human testing. A look at how Blindsight works & Neuralink’s ...
The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...
The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.
The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...
Blindsight aims to restore vision by implanting microelectrodes in the brain, though its ability to deliver clear, usable sight remains uncertain.
The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening ...
Neuralink, the Elon Musk-owned brain-computer interface company, has received "breakthrough device" clearance from the FDA.